The Massachusetts Life Sciences Center is giving the Forsyth Institute a $4.1 million capital grant to fund the new Forsyth Center for Salivary Diagnostics.
The facility will seek to revolutionize the way disease testing is performed, the organizations noted in a press release.
The center will develop and commercialize saliva-based tests to replace blood-based disease detection tests that are currently used. Saliva contains virtually all the same medical diagnostic information as blood, including DNA, proteins, and hormones.
Forsyth plans to work with multiple research partners and include targeted workforce training for biotechnology personnel in its quest to find biomarkers in saliva for diseases, including metabolic syndrome/prediabetes syndrome, tuberculosis, and strokes.
